cannabinoids

January 8, 2018January 8, 2018

MMJ Files Patent on Part-cannabinoid and Part-non-cannabinoid Treatment for MS

News

MMJ International Holdings is seeking a patent for a part-cannabinoid and part-non-cannabinoid treatment for multiple sclerosis and other diseases. The company said in a news release that it filed the patent ... Read more

November 29, 2017November 29, 2017

MMJ Files US Patent for Multiple Sclerosis Cannabinoid Treatment

News

MMJ International Holdings has applied to the U.S. Patent and Trademark Office (USPTO) for new pharmaceutical compounds and methods to treat and prevent symptoms associated with ... Read more

November 14, 2017November 15, 2017

MMJ Hires Lead Investigator for Phase 2 Trials of Medicinal Cannabis to Treat Progressive MS

News

MMJ BioScience, an affiliate of medical cannabis research company MMJ International Holdings, has hired a principal investigator to lead clinical trials exploring potential therapeutic applications of ... Read more

May 4, 2017June 7, 2017

6 Things to Know About Using Medicinal Marijuana

Using cannabis or marijuana for medicinal purposes is a hot topic right now among patients and health practitioners. It’s regularly touted as a pain reliever for many chronic ... Read more

February 23, 2017February 23, 2017

Brazil Allows HempMeds to Import RSHO Cannabidiol for MS Treatment

News

The Brazilian government has authorized HempMeds Brasil, a unit of California-based Medical Marijuana, to import the parent company’s hemp cannabidiol (CBD) oil flagship product — known as Real Scientific ... Read more

February 7, 2017February 7, 2017

95% of MS Patients Open to Marijuana Treatment, 73% Have Tried It

News

Ninety-five percent of multiple sclerosis (MS) patients believe medical marijuana should be a treatment option, according to a GeneFo online survey. The survey also showed that almost 73 percent had ... Read more

January 17, 2017January 17, 2017

Cannabis Compounds Ease Spasticity in MS, National Academies’ Report States

News

Certain cannabinoids reduce spasticity symptoms in multiple sclerosis (MS) patients, according to a report from The National Academies of Sciences, Engineering, and Medicine that scrutinized published research about the benefits and hazards of cannabis ... Read more

July 5, 2016July 5, 2016

Tremors Linked to MS Poorly Treated with Symptomatic Medication, Study Finds

News

Disabling tremors can affect as many as half of all people with multiple sclerosis (MS), but they are inadequately treated because of limited therapeutic options and are ... Read more

March 11, 2016

Multiple Sclerosis: Cannabinoids Can Control Spasticity and Tremor

In this video, watch Faculti Professor David Baker talk about how cannabinoids can be used to control spasticity and tremor in multiple sclerosis patients. Learn more about ... Read more

October 23, 2015October 26, 2015

Cannabis-Derived Sativex for MS-Related Spasticity Reported to Be Effective and Safe

Multiple Sclerosis News, News

Barcelona, Spain-based, global pharma firm Almirall presented new clinical evidence at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) ... Read more

Pin It on Pinterest